- Small Pharma ( OTCQB:DMTTF ) appoints Mr. George Tziras as CEO of the company succeeding founder Mr. Peter Rands, effective as of July 20, 2022.
- Mr. Peter Rands will take on the role of Chief Innovation & Intellectual Property Officer of the company and will continue to serve on the board following the transition.
- Mr. Tziras initially joined the company in 2015 as a director of the company’s main operating subsidiary, before also being appointed to the role of CBO and director of the company in 2021.
For further details see:
George Tziras is the new CEO of Small Pharma